DrugPatentWatch Database Preview
Investigational Drug Information for BGB-3111
Email this page to a colleague
What is the drug development status for BGB-3111?
BGB-3111 is an investigational drug.
There have been 97 clinical trials for BGB-3111.
The most recent clinical trial was a Phase 1 trial, which was initiated on December 1st 2018.
The most common disease conditions in clinical trials are Lymphoma, Neoplasms, and Carcinoma. The leading clinical trial sponsors are BeiGene, BeiGene USA, Inc., and German CLL Study Group.
There are seven US patents protecting this investigational drug and sixty international patents.
Summary for BGB-3111
| US Patents | 7 |
| International Patents | 60 |
| US Patent Applications | 29 |
| WIPO Patent Applications | 30 |
| Japanese Patent Applications | 5 |
| Clinical Trial Progress | Phase 1 (2018-12-01) |
| Vendors | 23 |
Recent Clinical Trials for BGB-3111
| Title | Sponsor | Phase |
|---|---|---|
| A Phase 1 Dose-Escalation and Expansion Study of BGB-16673 in Patients With B-Cell Malignancies | BeiGene | Phase 1 |
| Treatment of Relapsed/Refractory Multiple Myeloma With t 11;14 Translocation Using BGB-11417 With Dexamethasone; Also Using BGB-11417 in Combination With Dexamethasone and Carfilzomib. | BeiGene | Phase 1/Phase 2 |
| Ociperlimab With Tislelizumab and Chemotherapy in Patients With Untreated Metastatic Non-Small Cell Lung Cancer | BeiGene | Phase 2 |
Clinical Trial Summary for BGB-3111
Top disease conditions for BGB-3111
Top clinical trial sponsors for BGB-3111
US Patents for BGB-3111
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| BGB-3111 | ⤷ Free Forever Trial | Substituted pyrazolo[1,5-a]pyrimidines as bruton's tyrosine kinase modulators | BEIGENE, LTD. (Grand Cayman, KY) | ⤷ Free Forever Trial |
| BGB-3111 | ⤷ Free Forever Trial | Treatment of pemphigus | PRINCIPIA BIOPHARMA INC. (South San Francisco, CA) | ⤷ Free Forever Trial |
| BGB-3111 | ⤷ Free Forever Trial | Substituted pyrazolo[1,5-a]pyrimidines as Bruton's tyrosine kinase modulators | BEIGENE SWITZERLAND GMBH (Basel, CH) | ⤷ Free Forever Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for BGB-3111
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| BGB-3111 | Australia | AU2014256633 | 2033-04-25 | ⤷ Free Forever Trial |
| BGB-3111 | Brazil | BR112015025260 | 2033-04-25 | ⤷ Free Forever Trial |
| BGB-3111 | Canada | CA2902686 | 2033-04-25 | ⤷ Free Forever Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
